Search clinical trials for: Depatuxizumab mafodotin
Total 66 results
-
AbbVieCompletedGlioblastoma Multiforme | Malignant GliomaJapan
-
AbbVieCompletedGlioblastoma Multiforme
-
AbbVieRadiation Therapy Oncology GroupCompletedGlioblastoma | GliosarcomaUnited States, Argentina, Australia, Austria, Belgium, Brazil, Canada, China, Colombia, Czechia, France, Germany, Hong Kong, Ireland, Israel, Italy, Korea, Republic of, Mexico, Netherlands, New Zealand, Portugal, Russian Federation, Singapor... and more
-
AbbVieEuropean Organisation for Research and Treatment of Cancer - EORTCCompletedGlioblastomaUnited States, Australia, Austria, Belgium, Canada, Czechia, Finland, France, Germany, Hungary, Ireland, Italy, Korea, Republic of, Mexico, Netherlands, Poland, Singapore, Spain, Switzerland, Taiwan, United Kingdom
-
AbbVieTerminatedGlioblastoma MultiformeUnited States, Australia, Germany, Netherlands, United Kingdom
-
PETHEMA FoundationGlaxoSmithKlineRecruitingRELAPSED AND/OR REFRACTORY MULTIPLE MYELOMASpain
-
Medical University of ViennaNot yet recruitingMultiple Myeloma | Corneal Diseases | Corneal Cyst
-
M.D. Anderson Cancer CenterRecruiting
-
Cristiana Costa Chase, DONot yet recruitingRelapsed/Refractory Multiple MyelomaUnited States
-
M.D. Anderson Cancer CenterRecruiting
-
European Myeloma NetworkGlaxoSmithKlineRecruitingAL AmyloidosisGermany, Netherlands, France, Greece, Italy, United Kingdom
-
Medical College of WisconsinRecruitingRefractory Multiple Myeloma | Relapse Multiple MyelomaUnited States
-
University of PennsylvaniaGlaxoSmithKlineRecruiting
-
University of Texas Southwestern Medical CenterGlaxoSmithKlineRecruitingAL Amyloidosis | AmyloidosisUnited States
-
GlaxoSmithKlineRecruitingMultiple MyelomaUnited States, Greece, Korea, Republic of, Singapore
-
Jacob Soumerai, MDGlaxoSmithKlineRecruitingRelapsed Plasmablastic Lymphoma | Refractory Plasmablastic Lymphoma | Anaplastic Lymphoma Kinase Positive Large B-Cell LymphomaUnited States
-
GlaxoSmithKlineActive, not recruitingMultiple MyelomaUnited States, Spain, France, Germany, Australia, United Kingdom, Canada, Italy
-
GlaxoSmithKlineTerminatedRelapsed/Refractory Multiple MyelomaAustralia, Sweden, Canada
-
GlaxoSmithKlineTerminatedMultiple MyelomaUnited States
-
GlaxoSmithKlineRecruitingMultiple MyelomaUnited States, Italy, Poland, Spain, Taiwan, Brazil, Greece, Ireland, Mexico, Canada, Korea, Republic of, Germany, France, Australia, United Kingdom, Argentina, India, Thailand, Switzerland
-
Fondazione EMN Italy OnlusRecruiting
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineRecruitingMultiple MyelomaGreece, Korea, Republic of, United States
-
Janssen Research & Development, LLCWithdrawnRelapsed/ Refractory Multiple MyelomaUnited States, Poland
-
Yale UniversityGlaxoSmithKlineRecruitingMultiple MyelomaUnited States
-
Hellenic Society of HematologyGlaxoSmithKlineActive, not recruiting
-
Roswell Park Cancer InstituteGlaxoSmithKlineRecruiting
-
Universitätsklinikum Hamburg-EppendorfRecruitingMultiple Myeloma | Multiple Myeloma in RelapseGermany
-
GlaxoSmithKlineAvailable
-
University of FlorenceAzienda Ospedaliera Città della Salute e della Scienza di Torino; University... and other collaboratorsRecruitingMigraine | Chronic Migraine | Migraine Without Aura | Migraine With AuraItaly
-
GlaxoSmithKlineMerck Sharp & Dohme LLCCompletedMultiple MyelomaSpain, Germany, United States, Canada
-
Barbara J. CoffeyCompletedTourette's DisorderUnited States
-
M.D. Anderson Cancer CenterRecruiting
-
Gilead SciencesCompletedHIV-1 InfectionSpain, France, United States, Germany, Italy
-
UNC Lineberger Comprehensive Cancer CenterAstraZenecaRecruitingCentral Nervous System LymphomaUnited States
-
PETHEMA FoundationAdknoma Health ResearchRecruitingRelapsed Multiple MyelomaSpain
-
Kyowa Kirin, Inc.CompletedParkinson's Disease | Movement Disorder SyndromeUnited States
-
GlaxoSmithKlineActive, not recruitingMultiple MyelomaAustralia, Japan, Spain, Germany, Poland, Belgium, Israel, Italy, Russian Federation, Canada, New Zealand, Korea, Republic of, China, Brazil, Czechia, United States, Netherlands, United Kingdom, Greece, France
-
Memorial Sloan Kettering Cancer CenterRecruiting
-
Hackensack Meridian HealthMerck Sharp & Dohme LLCWithdrawnMultiple Myeloma, RefractoryUnited States
-
GlaxoSmithKlineIqvia Pty LtdActive, not recruitingMultiple MyelomaUnited States, Australia, Spain, United Kingdom, Canada
-
Seagen Inc.TerminatedLymphoma, Large B-Cell, Diffuse | Follicular Lymphoma, Grade 3b | Lymphoma, B-cell | Lymphoma, Follicular, Grade 3bUnited States
-
Wake Forest University Health SciencesGlaxoSmithKline; AmgenActive, not recruitingMultiple MyelomaUnited States
-
GlaxoSmithKlineActive, not recruiting
-
GlaxoSmithKlineRecruitingMultiple MyelomaUnited States, Australia, Italy, Japan, Poland, Spain, United Kingdom, France, Germany, Greece, Canada, China, Israel, Korea, Republic of, Brazil, Russian Federation, Czechia, New Zealand, Turkey
-
GlaxoSmithKlineRecruitingMultiple MyelomaAustralia, Germany, Italy, Spain, United States, Korea, Republic of, Canada, France, Poland, United Kingdom
-
Hellenic Society of HematologyGlaxoSmithKlineRecruitingNeoplasms | Multiple Myeloma | Neoplasms, Plasma Cell | Paraproteinemias | Blood Protein Disorders | Corneal Disease | Gammopathy, Monoclonal | Haematologic DiseaseGreece
-
PETHEMA FoundationGlaxoSmithKlineRecruitingMultiple MyelomaSpain
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingLocally Advanced Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | ROS1 Gene Rearrangement | Stage IIIB Lung Non-Small Cell Cancer AJCC v7 | Stage IV Lung Non-Small Cell Cancer AJCC v7 | ALK PositiveUnited States
-
Massachusetts General HospitalSanofi; GlaxoSmithKlineNot yet recruitingMultiple Myeloma | Refractory Multiple Myeloma | Relapsed CancerUnited States